Bicara Therapeutics Inc. (CIK: 0002023658) EDGAR, Information, Filings... CompaniesBIO.Com

Bicara Therapeutics Inc.

Mailing address
245 MAIN STREET, CAMBRIDGE, Delaware, 02142
Phone
617-785-8308
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Bicara Therapeutics Inc. (CIK: 0002023658) is an American company incorporated in the state of Massachusetts. Head office is located at 245 MAIN STREET, CAMBRIDGE, Massachusetts, 02142. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Bicara Therapeutics Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Bicara Therapeutics Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-26-015423 ( Act) Size: 0 KB	Mar-05-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-26-015421 ( Act) Size: 0 KB	Mar-05-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-26-015419 ( Act) Size: 0 KB	Mar-05-2026
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000297 (33 Act) Size: 0 KB	Mar-05-2026	001-42271 26726059
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000283 (33 Act) Size: 0 KB	Mar-04-2026	001-42271 26721928
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000282 (33 Act) Size: 0 KB	Mar-04-2026	001-42271 26721905
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000280 (33 Act) Size: 0 KB	Mar-04-2026	001-42271 26721637
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000275 (33 Act) Size: 0 KB	Mar-03-2026	001-42271 26715620
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000274 (33 Act) Size: 0 KB	Mar-03-2026	001-42271 26714197
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000272 (33 Act) Size: 0 KB	Mar-03-2026	001-42271 26714097
SCHEDULE 13D/A	Document	Acc-no: 0001346824-26-000066 (34 Act) Size: KB	Mar-02-2026	005-94620 26708081
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001231919-26-000231 ( Act) Size: 0 KB	Mar-02-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-26-012823 ( Act) Size: 0 KB	Feb-27-2026
8-K	Document	Current report filing Acc-no: 0001193125-26-076560 (34 Act) Size: KB	Feb-26-2026	001-42271 26687857
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-26-072875 (33 Act) Size: KB	Feb-26-2026	333-290707 26681390
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001969223-26-000230 (33 Act) Size: 0 KB	Feb-25-2026	001-42271 26678368
FWP	Document	Filing under Securities Act Rules 163/433 of free writing prospectuses Acc-no: 0001193125-26-068187 (34 Act) Size: KB	Feb-25-2026	333-290707 26673981
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-26-067160 (33 Act) Size: KB	Feb-24-2026	333-290707 26672046
8-K	Document	Current report filing Acc-no: 0001628280-26-009808 (34 Act) Size: KB	Feb-19-2026	001-42271 26654966
SCHEDULE 13G/A	Document	Acc-no: 0000902664-26-001089 (34 Act) Size: KB	Feb-17-2026	005-94620 26641257

Recent 20 filings. View all Bicara Therapeutics Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Bicara Therapeutics Inc. overview
Bicara Therapeutics Inc. job
Bicara Therapeutics Inc. stock
Bicara Therapeutics Inc. ownership
Bicara Therapeutics Inc. CEO
Bicara Therapeutics Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.